SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: David Israel-Rosen who wrote (550)4/5/1998 6:04:00 PM
From: Ariella  Read Replies (1) | Respond to of 1491
 
Interesting links......

a) see item 2 on link. Raphael Mecholam, responsible for Hu-211, was in New York two weeks ago....(we should have invited him out for coffee!)
marijuananews.com

b) NIH report on uses of marijuana in medicine
pharmacology.miningco.com

c) Israeli Industry Center for R&D (Matimop) -- online ads PARS has for research partners for HU-211 and Tamoxifen, including $ support desired, and responsibilities of partner.....

matimop.org.il
matimop.org.il
matimop.org.il

Comments welcome--
Ariella